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Abstract
Background: The use of elastomeric devices for ambulatory intravenous pain treatment in Major Ambulatory
Surgery (MAS) has been described to improve postoperative pain management. The objective of the study was to
describe the first 3 years experience of the use of elastomeric devices for ambulatory intravenous pain treatment in
MAS implemented at our site since 2010.
Methods: Data were retrieved from the medical records for all patients who, between January 2010 and March
2014, underwent surgical procedures at the ambulatory surgical centre at our hospital and were prescribed a
home-based continuous intravenous analgesia.
Results: Data were retrieved from the medical records of 1128 patients. The most frequent surgical interventions
included orthopedic and proctology surgeries. 80 % of patients were discharged home without pain; during the
first 48 h after discharge roughly 40 % of subjects were completely free of pain, 50 % reported mild pain (VAS 1
to 3) and 9 % reported higher pain scores (4 and above). Peripheral nerve block was associated to better pain
control in the immediate postoperative period. Vomiting in the first 24 h was 4.6 % before introducing haloperidol into
the drug schemes, and 2.6 % thereafter. Complications related with the intravenous route required treatment
withdrawal in 1.1 % cases. Only 3.5 % of patients returned to the hospital in the first 72 h, mainly for non-pain
related reasons. Overall, 99.5 % of patients were satisfied with the treatment received at home.
Conclusion: Our initial experience suggest that outpatient multimodal intravenous analgesia in patients undergoing
day-case surgery is a feasible alternative in our setting, that allows an effective management of postoperative pain with
a small rate of adverse events and complications requiring readmission.
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Background
Acute postoperative pain (APP) and postoperative nau-
sea and vomiting are the most frequent clinical prob-
lems after Major Ambulatory Surgery (MAS). They
complicate the recovery, delaying patient discharge or
increasing the rate of readmission after discharge. The
development of new minimally invasive surgical tech-
niques, the progress in anesthesia and new systems for
administration of analgesics have been instrumental to
expand the scope of surgical procedures that can be
done in MAS settings, including interventions which
were previously discarded mainly due to the difficulties
to achieve an appropriate control of APP [1, 2].
An appropriate control of pain is a healthcare quality
indicator having social and economical implications.
However, in US and Canada, where about 70 % of surgi-
cal procedures are MAS, 30 % of subjects undergoing
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ambulatory surgery yet suffer moderate to severe pain in
the first 24 h after surgery, despite receiving analgesic
treatment [3]. Thus, there is a need to do a careful selec-
tion of those procedures and the patients which are
appropriate for ambulatory surgery in each specialty [4].
There is general agreement on multimodal analgesia
as the most appropriate analgesia in MAS [1, 5–9]. In
our setting, the ASECMA (Asociación Española de
Cirugía Mayor Ambulatoria- Spanish Association for
Major Ambulatory Surgery) subscribed a joint consen-
sus document with other medical-surgical societies,
which includes a statement on the need to apply a
multidisciplinary, multimodal and individualized ap-
proach to surgical pain management [10].
Post-operative pain in MAS should be approached
already before surgery, with home preoperative medica-
tion, and consolidated in the intra-operative period with
appropriate anesthesia and analgesia; in particular, nerve
blockades, infiltrations and/or instillation of surgical
wounds with long lasting local anesthetics have proven
to be very effective and should be done systematically
[3]. In the postoperative period, pain management is
based on intravenous analgesia while still in the ambula-
tory surgery unit (ASU), followed by ambulatory anal-
gesia at patient’s home [11–13]. While oral analgesia at
home obtains good results when mild to moderate pain
is expected, some studies have shown that it has high
rates of failure in moderate to severe pain, with up to
7 % of patients requiring hospitalization and intravenous
treatment for uncontrolled postoperative pain [14, 15].
The availability of elastomeric infusion systems and
pumps for intravenous administration both as continu-
ous infusion and as patient controlled analgesia (PCA)
allow stable plasma concentrations of drugs which
achieve better control of pain, thus improving efficacy
and reducing adverse effects as compared to bolus ad-
ministration [16, 17].
At our site and in parallel to an early discharge pro-
gram in MAS, we introduced the use of elastomeric de-
vices for early treatment of postoperative pain in MAS
patients on 2008, with the aim to improve postoperative
pain management in the first days after surgery. On
January 2010 a formal protocol for analgesia in postoper-
ative pain in patients undergoing ambulatory surgery
was issued and implemented, which included the use of
elastomeric pumps for intravenous analgesia before and
after discharge, covering the first 48 to 96 h after surgery
depending on the degree of expected pain for each type
of surgery. The protocol includes close monitoring by
nursing staff for as long as the patient is receiving intra-
venous treatment.
The present report summarizes the three year experi-
ence with the protocol for domiciliary intravenous anal-
gesia for the treatment of postoperative pain after major
ambulatory surgery, with special emphasis on describing
the pain control achieved, and with the aim to identify
any specific safety problems that may arise from the ap-
plication of domiciliary analgesia.
Methods
Design
An early discharge program in MAS with nurse-driven
ambulatory follow up was implemented on January
2010. As a part of pain management, the protocol in-
cluded the use of elastomeric pumps for continuous
intravenous analgesia administration during the first 48
to 96 h post-surgery. In February 2014, an observational
retrospective study was designed aimed to describe the
initial experience regarding the effectiveness and safety
of the use of elastomeric pumps for analgesia in this set-
ting. The study protocol was reviewed and approved by
an independent ethic’s committee (CEIC Corporació
Sanitaria Parc Taulí, Sabadell) on March 4th 2014; the re-
quirement for written informed consent was waived by
the institutional review board.
Patients
Data were retrieved from the medical and nursing re-
cords for all patients who, between January 2010 and
March 2014, underwent surgical procedures in the
CQA (ambulatory surgical centre, Hospital de Sabadell,
Barcelona) and were prescribed a home-based continu-
ous intravenous analgesia (HBCIA); a semi-structured
questionnaire was used for patient follow-up as a part
of the protocol activities. Table 1 summarizes the type
of surgeries that the protocol established as potential
candidates and the exclusion criteria for home-based iv
analgesia.
Treatments
During this period, five different analgesic schemes were
used for HBCIA (Table 2). The choice of scheme for a
given patient was decided by the anesthesiologist accord-
ing to the patient’s characteristics (type of surgery, age,
weight and safety considerations).
The elastomeric pumps used were Infusor Folfusor
SV 2 (Baxter) which is a portable and disposable non-
electronic small volume infuser with nominal flow rate
of 2 mL/h and a maximum volume of 130 mL, which
allows a slow continuous infusion over 48 h. The
pumps were prepared by the hospital Pharmacy Depart-
ment and delivered to the CQA, where nursing
personnel could add to the pump customized anti-
emetic medications according to the postoperative
medical prescriptions.
Infusions using HBCIA elastomeric pumps were
started either at the anesthetic reanimation room or at
the so called unit for adaption to environment, and were
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maintained for 48 h, regardless of patient discharge to
their home. Patients were instructed on general care of
venous access and pump care. After 24 h patients re-
ceived a follow-up call by a nurse, and at 48 h they re-
ceived a nurse visit at home; in some cases, a new pump
was replaced during this visit to prolong HBCIA for
additional 24 h or even 48 h (mainly limited to hemor-
rhoidectomies), as prescribed depending on the intensity
of pain. At the end of the prescribed period (48 h, 72 h
or 96 h) the nurse retired the pump and iv access, in
addition to reviewing of wounds and dressings, and
checked pain and wellbeing. At any time, nurses solved
problems derived from the infusion (extravasation, dis-
location of the route), or stopped the infusion in case of
adverse reactions (nausea, phlebitis…) and derived to the
hospital any problem related with the infusion, the drugs
infused or any postoperative complication which re-
quired medical assessment.
Outcomes and measurements
Medical and nursing records were reviewed to retrieve
demographic data, surgical and anesthetic procedures,
and treatments administered before hospital discharge
and during the post-surgery period.
The main effectiveness assessments were numerical
rating scales (0–10) for post-operative pain which were
routinely assessed by the semi-structured form used by
nurses for patient follow-up, as a part of the protocol ac-
tivities, at entry and discharge of each care unit, and also
once daily during ambulatory care.
Also, safety information was obtained from the routine
assessments performed before discharge and after during
ambulatory visits. The semi-structured forms included
assessments for presence of nausea, vomiting, somno-
lence and pruritus, need for analgesic rescue medication,
incidences with the infusion system and patient satisfac-
tion (satisfied or not satisfied). Any further hospital ad-
missions or visits to emergency ward were retrieved
from the hospital admission records.
Statistical methods
Quantitative variables were described and are presented
as mean ± standard deviation, and qualitative variables
with number and percentages, considering the different
transitions of care from reanimation to the unit for
adaption to environment, and then daily for the home
care period, either on the phone or during a home visit.
The numerical pain rating scale was categorized as no
pain (0), mild pain (1–3), moderate pain (4–6) and in-
tense pain (7–10).
Results
From January 2010 to March 2014, 1135 patients
underwent major outpatient surgery at CQA who were
prescribed home-based analgesia with an elastomeric
pump. Of these, 5 patients did not finally receive treat-
ment with elastomeric pumps: 4 because they were
admitted to regular hospitalization due to nausea, sick-
ness or pain, during the immediate postoperative
period, and 1 due to technical problems with the pump
which precluded its use. Two more patients were ex-
cluded from description because no nursing visits were
done in the first two days due to logistic problems
(snow storm). Table 3 describes the characteristics of
the remaining 1128 patients. The majority of patients
underwent orthopedic surgeries. Throughout the years
the number of treated patients per year increased from
216 in 2010 to 299 in 2013, paralleling increases in
MAS activity at our site.
Table 1 Criteria for home based intravenous analgesia
following major ambulatory surgery
Criteria for home-based continuous intravenous analgesia (HBCIA) after
ambulatory surgery at our centre
− Type of surgeries eligible for home based iv analgesia
− Shoulder surgeries: acromioplasty and other shoulder arthroscopic
procedures
− Upper limbs surgeries: arthroplasty, rhizarthrosis surgery, osteotomy,
osteosynthesis
− Lower limb surgeries: knee ligamentoplasty, hallux valgus surgery,
foot osteotomy, foot arthroplasty
− Proctologic surgery
− Any surgery anticipated to induce moderate or intense pain.
Patients not candidates for invasive home analgesia
− Patients with cognitive dysfunction
− History of drug abuse or psychiatric disease
− Patients without family support at home
− Patients with known drug allergies
− Patients that live within a distance from the hospital considered
too far that would make the visit of the nurses not feasible
Table 2 Description of the different elastomeric pumps
N %
Description
Tramadol 400 mg + dexketoprofen 250 mg + haloperidol
2,5 mg in physiological saline (total volume 100 cc),
2 ml/h, 48 h
912 80.1 %
Tramadol 400 mg + dexketoprofen 250 mg in
physiological saline (total volume 100 cc), 2 ml/h, 48 h
154 13.6 %
Tramadol 200 mg + dexketoprofen 100 mg in
physiological saline (total volume 50 cc), 2 ml/h, 24 h
40 3.5 %
Tramadol 300 mg + 2.5 mg haloperidol in physiological
saline (total volume 100 cc), 2 ml/h, 48 h
Ibuprofen 600 mg/8 h oral route
12 1.1 %
Tramadol 400 mg +metamizole 2 g in physiological
saline (total volume 100 cc), 2 ml/h, 48 h
5 0.44 %
Not registered 5 0.44 %
Total 1128
All patients were prescribed Paracetamol 1 g/6 h oral route, gastric protection
and metoclopramide 10 mg/12 oral route if needed
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Table 4 describes the type of anesthesia performed.
Most patients (67.5 %) received a peripheral nerve block,
either as a single anesthetic technique or on top of gen-
eral or intradural anesthesia. Pre-emptive analgesia with
NSAIDs was administered to 71 % for patients undergo-
ing shoulder surgery, but only to 16.9 % in foot interven-
tions. Antiemetic prophylaxis with a single preoperative
dose of dexamethasone was given to 78.5 % of patients.
The type of multimodal analgesia used in the elasto-
meric pumps is described in Table 2. Until November
2010 haloperidol was rarely prescribed (8.8 %). At that
time an interim review of data suggested that nausea
and vomiting were frequent, so it was decided to system-
atically consider adding an antiemetic prophylaxis with
haloperidol unless contraindicated. Since that date,
94.5 % of patients received treatment regimens contain-
ing haloperidol.
According to the routine pain assessments, most pa-
tients were free of pain immediately after surgery, and
only 11.3 % presented moderate or intense pain (pain
scores ≥ 4). As expected, knee and shoulder surgery were
the most painful interventions with 22.3 % and 25.2 % of
patients presenting at least moderate pain, respectively.
Nearly 80 % of patients were discharged home without
pain, and around 40 % referred to be completely free of
pain at home after 24 and 48 h from surgery (Fig. 1). Pa-
tients who had undergone hemorrhoid surgery were pre-
scribed longer schedules up to 72–96 h, and often
showed peak pain values appearing at 72–96 h (data not
shown in the figure).
Overall, patients who had received a peripheral nerve
block had better control of pain during the immediate
postoperative period, while still at the hospital, as com-
pared to patients without nerve block (% of patients
without pain 72.5 % and 48.5 % respectively). 15.4 % of
patients used rescue medication with oral tramadol at
some time on top of their HBICA.
Adverse reactions were infrequent. Intravenous treat-
ment was retired in 5 cases due to emesis and in 8 cases
due to other adverse reactions (3 allergic reactions, 3
cases of unspecified intolerance to drugs or infusion
pump and 2 arterial thromboses). Complications related
with the intravenous route included extravasation in 15
(1.3 %) patients and phlebitis in 4 patients. In 12 (1.1 %)
cases the route had to be replaced or retired due to tech-
nical problems. During the first 72 h after surgery, 40
patients (3.5 %) returned to the hospital. Figure 2 shows
the reasons that were coded in the hospital admission
records. Most cases (15) consisted on programmed visits
related with the control of the surgical procedure. Table 5
shows the percentage of patients reporting nausea and
vomiting during hospital stay, and nausea, vomiting,
somnolence and pruritus when called or visited by
nurses at home. The incidence of vomiting at 24 h was
Table 3 Description of the studied population
N %
Gender
Male 467 41.4 %
Females 661 58.6 %
ASA
ASA 1 370 32.9
ASA 2 668 59.2
ASA 3 70 6.2
Not registered 20 1.8
Type of surgery
Foot 431 38.2 %
Hand 148 13.1 %
Knee 157 13.9 %
Shoulder 210 18.6 %
Ano-rectal 123 10.9 %
Others 59 5.2 %
Mean (SD) range
Age (years) 49.60 (16.01) 15 - 87
Total 1128
Table 4 Type of anesthesia and premedication with NSAIDs
and dexamethasone
N %
Type of anesthesia
General Anesthesia 440 39.0
+ peripheral nerve block 255 22.6
Intradural anesthesia 186 16.5
+ peripheral nerve block 9 0.8
Peripheral nerve block only 497 44.1
Sedation ± local infiltration 5 0.4
Total 1128 100 %
Any peripheral nerve block
Yes 761 67.5 %
No 367 32.5 %
Total 1128 100 %
Type of peripheral nerve block
Suprascapular nerve block 219 28.8 %
Supraclavicular nerve block 40 5.3 %
Foot nerve block 412 54.1 %
Axillary nerve block 85 11.2 %
Other (popliteal, femoral, interscalene) 5 0.7 %
Total 761 100 %
Premedication
Dexamethasone 886 78.5 %
NSAIDs 410 36.3 %
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generally higher in women, and nearly halved after anti-
emetics were systematically considered as a part of the
schedule, since November 2010 (from 4.6 % to 2.6 %).
Pre-treatment with dexamethasone, which was given at
the anesthesiologist criteria was associated to a vomiting
incidence of 2.3 % as compared to 5.8 % when not given.
Overall, 99.5 % of patients were satisfied with the treat-
ment received at home.
Discussion
Our series describes the experience of more than 3 years
with an early discharge program in MAS, in which we
introduced the use of elastomeric devices for early treat-
ment of postoperative pain that was extended after dis-
charge, including home-based continuous intravenous
analgesia.
In our 1128 patient series, we have observed that pain
control while at the surgical centre allowed that 80 % of
patients were discharged home with no pain, and that
during the first 48 h after discharge, roughly 90 % of
subjects were either completely free of pain or reported
mild pain scores. However, yet a 9 % reported pain
scores of 4 and above.
Most patients received a 48 h infusion and then were
switched to oral route; for these, no further pain assess-
ments were available since they were considered com-
pleted as regards to special follow-up. Only patients
undergoing surgeries considered to be very painful re-
ceived extended infusions and were followed over 72 or
even 96 h; this may be the reason why our data show
worse pain control rates at 72 h, with a proportion of
patients with scores ≥ 4 up to 14 %.
We consider that our results may be regarded as good,
as compared to similar series in both inpatient and out-
patient setting. In a case series from the Netherlands,
moderate to severe postoperative pain was present in
41 % of hospitalized patients on the first day of surgery,
and in 15 % of patients on the 4th day [18]. In the
Fig. 1 Visual analogue scale results for pain at different times
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outpatient setting after day-case surgery, on the first
24 h after hospital discharge, Pavlin et al. reported that,
up to 60 % of patients reported pain > 4 and up to 20 %
pain > 7 [19], and McHugh et al. reported 30 % of pa-
tients reported moderate to severe pain, in both cases
measured with a verbal rating scale administered during
a telephonic survey [20]. Gramke et al. reported that
21 %, 13 % and 10 % of patients had pain VAS > 4 on
postoperative days 1, 2, and 3, respectively [21]. To note,
most of these series, like ours, include a number of dif-
ferent procedures, mainly orthopedic surgery, but also
ear-nose and throat, abdominal, gynecological and breast
surgery. Gramke suggests that in his series a number of
procedures (head and neck, orthopedic, abdominal and
breast plastic surgery) were associated with higher pain
[21]. We observed that knee and shoulder surgery were
associated with higher pain, but better control of early
pain when peripheral nerve block was used during sur-
gery. Thus, it seems reasonable to promote the use of per-
ipheral nerve blocks whenever indicated in these patients.
Also, hemorrhoidal surgery was associated with longer-
lasting pain, peaking at 72 h, thus justifying the extension
of HBCIA up to 96 h in this particular procedure.
All the therapeutic schemes in the elastomeric pumps
that were used during the studied period contained
tramadol, and almost all (> 97 %) combined both trama-
dol and dexketoprofen. Routine use of tramadol has
been controversial, since nausea and vomiting have been
described in up to 40 % of treated patients in some
series [22, 23]. Rawal et al. reported that use of oral
tramadol after day-case surgery was associated to nausea
and dizziness in up to 17.5 %, leading to withdrawal in
several patients, and was also associated to patient dis-
satisfaction [24]. Our experience suggests that tramadol
is well tolerated when administered as a part of multi-
modal analgesia by continuous perfusion, and that toler-
ability may be improved by adding an antiemetic to the
elastomeric pumps. Actually, in our series only 5/1135
(< 0.5 %) patients required treatment withdrawal due to
vomiting.
Regarding other clinical outcomes, it is remarkable
that we observed a low incidence of complications re-
lated to the intravenous route, like extravasation or phle-
bitis, and the need to replace the venous access or to
withdraw the intravenous treatment occurred only in
1.1 % of cases [25]. Also, it is relevant that the main rea-
sons by which patients returned to the hospital in the
first 72 h after surgery were not related to pain.
One of the key aspects of our outpatient program is
the domiciliary patient follow-up, combining telephonic
and in-person nursing care in the early postoperative
period. The program uptake was remarkably well ac-
cepted by medical and nursing staff [26], but also pa-
tients indicated a high rate of satisfaction in our series.
Routine control; 15
Complication 
surgery; 9
Complication 
infusion; 2
Adverse reaction; 3
Pain; 2
Other; 3
Unknown; 6
Fig. 2 Reasons for post-discharge (within 72 h) patients visits to
the hospital
Table 5 Adverse reactions reported
N %
Nausea and vomiting – surgical wards
Post-anesthetic resuscitation unit 23 2 %
Male 13 2.9 %
Female 10 1.5 %
Adaptation to media unit 4 0.4 %
Male 2 0.4 %
Female 2 0.3 %
Nausea and vomiting 24 h
Nausea 60 5.3 %
Male 10 2.1 %
Female 50 7.6%a
Vomiting 34 3 %
Male 3 0.6 %
Female 31 4.7%a
Nausea and vomiting 48 h
Nausea 61 5.4 %
Male 12 2.6 %
Female 49 7.4%a
Vomiting 33 2.9 %
Male 4 0.9 %
Female 29 4.4%a
Somnolence
24 h 112 9.9 %
48 h 143 12.7 %
Pruritus
24 h 13 1.2 %
48 h 21 1.9 %
Patients with at least 1 event 318 28.2 %
Total 1128
aP < 0.01 for Chi-squared comparisons between males and females
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There are a number of limitations to our report. First,
this is a report of our clinical experience. Data has been
collected retrospectively from clinical charts and simple
forms that were designed for clinical purposes during
the ambulatory follow at the time of program implemen-
tation, and thus the information has not been collected
in a standardized and prospective way intended for re-
search purposes. Thus the results reported should be
considered within this observational perspective, espe-
cially as regards to effectiveness. Also, it has been previ-
ously reported that several risk factors can be identified
to predict the requirement of prolonged stay in ambula-
tory surgery [27]. Since the identification of risk factors
was not amongst our objectives, in the present study we
did not collect a wide description of medical antecedents
and conditions of our patients. In the future we may de-
scribe different patient profiles with differential require-
ments, as we increase our experience and collect
additional information on small subgroups with higher
risk of poor pain control, adverse events or requirements
of close medical care.
We present aggregated data for many different surgeries
that are known to have quite different pain management
requirements and characteristics, and report joint results
for a number of different drug preparations. Besides, the
type of drug combinations used along the program imple-
mentation have been slightly modified in time, so that
i. ex. antiemetic drugs, mainly haloperidol, were added to
the elastomeric preparations after first year. However, the
availability of a number of combinations allowed personal-
ized choices according to each subject characteristics, con-
sidering allergies, comorbidities, risks for adverse events
and type of surgery. Likely, a reasonable degree of flexibil-
ity may be useful to maintain a low rate of complications
and improve clinical results.
Conclusions
Our data suggest that an approach based on extending
the intravenous multimodal analgesia after discharge has
proven to be feasible and appropriate in a wide series of
patients in our setting, and in many surgical procedures,
and has proven safe and easy to apply within the param-
eters defined by our program. Whether this approach
may be translated to other settings is uncertain, since
the availability of resources, the relatively close proxim-
ity of the geographical area to cover, and the easiness of
arrangements for home visits after discharge may be dif-
ficult to reproduce in other geographies and health sys-
tem models. We have observed an effective management
of postoperative pain with an acceptable rate of adverse
events and complications, and the process has been feas-
ible and well accepted by all involved parties. We think
that our experience may be useful to other groups who
may be considering strategies aimed to enhance patient
access to surgical procedures, and since the objectives of
the program have been achieved, these results reinforce
its continuation and suggest the convenience to consider
the extension of the model to other types of surgeries.
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